返回
L
Long Ma
Gilead Sciences, Inc.
2H指数
9论文数
15被引数
收录论文 3
发表时间
A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)一项关于sacituzumab govitecan与医生选择治疗方案在经过铂类化疗和免疫治疗后的子宫内膜癌患者中的随机、III期研究:ASCENT-GYN-01研究(GOG-3104/ENGOT-en26/APGOT-EN2)。

